Fda panel split over smokeless tobacco warnings
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:

An FDA advisory panel voted on claims put forward by Swedish Match, a smokeless tobacco manufacturer, on Friday, _Time_ reports. The company wants to do away with warning labels on its
smokeless tobacco product snus, arguing that snus presents "substantially lower risks to health than cigarettes." The committee split on the question of whether using smokeless
tobacco products really is substantially safer than smoking cigarettes; Swedish Match's argument is effectively one of harm reduction, suggesting that the lower level of nicotine in
snus provides a relatively safer experience for those who choose to use a tobacco product. The committee agreed, though, against doing away with Swedish Match's warning label, saying
the claims the company put forward do not prove that the product does not pose any health risks. SUBSCRIBE TO THE WEEK Escape your echo chamber. Get the facts behind the news, plus analysis
from multiple perspectives. SUBSCRIBE & SAVE SIGN UP FOR THE WEEK'S FREE NEWSLETTERS From our morning news briefing to a weekly Good News Newsletter, get the best of The Week
delivered directly to your inbox. From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox. The FDA does not necessarily
have to adopt the advisory committee's findings, but it will use them as a recommendation. Explore More STEM Speed Reads